AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples